Disease-inducing Potential of Two Leukemic Cell Lines in a Xenografting Model

Overview

Journal J Assist Reprod Genet

Publisher Springer

Specialties Genetics
Reproductive Medicine

Date 2021 Mar 31

PMID 33786735

Citations 1

Authors

D D Manavella

Sonia Herraiz

M Soares

A Buigues

A Pellicer

J Donnez

C Diaz-Garcia

M M Dolmans

Affiliations

Soon will be listed here.

Abstract

Purpose: Cryopreserved ovarian tissue transplant restores ovarian function in young cancer patients after gonadotoxic treatment. However, leukemia is associated with increased risk of malignant cell transmission. We aimed to assess the tumor-inducing potential of two different leukemic cell lines when xenografted to immunodeficient mice.

Methods: Fifty-four female immunodeficient mice were grafted with either 100, 200, 500, 1000, and 10,000 chronic myeloid leukemia in blast crisis (BV-173) cells or relapsed acute lymphoblastic leukemia (RCH-ACV) cells, embedded inside a fibrin scaffold along with 50,000 human ovarian stromal cells. Two mice per cell line received the fibrin matrix without leukemic cells as negative controls. Clinical signs of disease were monitored for 20 weeks. Grafts, liver tissue, and masses were collected for macroscopic analysis and gene expression of BCR-ABL1 and E2A-PBX fusion transcripts present in BV-173 and RCH-ACV respectively.

Results: BV-173 cells: Mice grafted with 100, 200, or 500 cells showed no sign of disease after and were negative for BCR-ABL1 expression. Three of the 5 animals grafted with 1000 cells and all mice with 10,000 cells developed disease and showed BCR-ABL1-positive expression. RCH-ACV cells: Two out of 4 mice grafted with 100 cells developed disease and were E2A-PBX1-positive. All the animals grafted with higher cell doses showed signs of disease and all but one were E2A-PBX1-positive.

Conclusion: The present work proves that the disease-inducing potential of BV-173 and RCH-ACV leukemic cells xenografted to SCID mouse peritoneum differs between cell lines, depending on cell number, type, status, and cytogenetic disease profile when ovarian tissue is harvested.

Citing Articles

Evaluating the safety and efficacy of cryopreserved ovarian tissue transplantation in leukemia patients with different bone marrow remission status using xenotransplantation.

Li Y, Ruan X, Gu M, Du J, Jin F, Cheng J Front Endocrinol (Lausanne). 2024; 15:1364316.

PMID: 38590823 PMC: 10999602. DOI: 10.3389/fendo.2024.1364316.

References

Soares M, Saussoy P, Sahrari K, Amorim C, Donnez J, Dolmans M . Is transplantation of a few leukemic cells inside an artificial ovary able to induce leukemia in an experimental model?. J Assist Reprod Genet. 2015; 32(4):597-606. PMC: 4380902. DOI: 10.1007/s10815-015-0438-x. View

Hermann B, Sukhwani M, Salati J, Sheng Y, Chu T, Orwig K . Separating spermatogonia from cancer cells in contaminated prepubertal primate testis cell suspensions. Hum Reprod. 2011; 26(12):3222-31. PMC: 3212882. DOI: 10.1093/humrep/der343. View

McGuirk J, Yan Y, Childs B, Fernandez J, Barnett L, Jagiello C . Differential growth patterns in SCID mice of patient-derived chronic myelogenous leukemias. Bone Marrow Transplant. 1998; 22(4):367-74. DOI: 10.1038/sj.bmt.1701343. View

Asano K, Wakabayashi H, Kikuchi N, Sashika H . Acute myeloid leukemia presenting with complete paraplegia and bilateral total blindness due to central nervous system involvement. Spinal Cord Ser Cases. 2017; 2:15035. PMC: 5129448. DOI: 10.1038/scsandc.2015.35. View

Silber S, DeRosa M, Goldsmith S, Fan Y, Castleman L, Melnick J . Cryopreservation and transplantation of ovarian tissue: results from one center in the USA. J Assist Reprod Genet. 2018; 35(12):2205-2213. PMC: 6289920. DOI: 10.1007/s10815-018-1315-1. View

Gopakumar K, Rajeswari B, Chandar R, Nair R, Thankamony P . Spontaneous intramedullary hematoma and leukemic deposit in spinal cord causing acute onset paraplegia in a child with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2018; 65(8):e27075. DOI: 10.1002/pbc.27075. View

Dolmans M, Marinescu C, Saussoy P, Van Langendonckt A, Amorim C, Donnez J . Reimplantation of cryopreserved ovarian tissue from patients with acute lymphoblastic leukemia is potentially unsafe. Blood. 2010; 116(16):2908-14. DOI: 10.1182/blood-2010-01-265751. View

Luyckx V, Dolmans M, Vanacker J, Legat C, Moya C, Donnez J . A new step toward the artificial ovary: survival and proliferation of isolated murine follicles after autologous transplantation in a fibrin scaffold. Fertil Steril. 2014; 101(4):1149-56. DOI: 10.1016/j.fertnstert.2013.12.025. View

Zver T, Alvergnas-Vieille M, Garnache-Ottou F, Roux C, Amiot C . A new method for evaluating the risk of transferring leukemic cells with transplanted cryopreserved ovarian tissue. J Assist Reprod Genet. 2015; 32(8):1263-6. PMC: 4554377. DOI: 10.1007/s10815-015-0512-4. View

10.

Diaz-Garcia C, Herraiz S, Such E, Del Mar Andres M, Villamon E, Mayordomo-Aranda E . Dexamethasone does not prevent malignant cell reintroduction in leukemia patients undergoing ovarian transplant: risk assessment of leukemic cell transmission by a xenograft model. Hum Reprod. 2019; 34(8):1485-1493. DOI: 10.1093/humrep/dez115. View

11.

Luyckx V, Dolmans M, Vanacker J, Scalercio S, Donnez J, Amorim C . First step in developing a 3D biodegradable fibrin scaffold for an artificial ovary. J Ovarian Res. 2013; 6(1):83. PMC: 4176293. DOI: 10.1186/1757-2215-6-83. View

12.

Donnez J, Dolmans M . Fertility Preservation in Women. N Engl J Med. 2017; 377(17):1657-1665. DOI: 10.1056/NEJMra1614676. View

13.

Vanacker J, Luyckx V, Dolmans M, des Rieux A, Jaeger J, Van Langendonckt A . Transplantation of an alginate-matrigel matrix containing isolated ovarian cells: first step in developing a biodegradable scaffold to transplant isolated preantral follicles and ovarian cells. Biomaterials. 2012; 33(26):6079-85. DOI: 10.1016/j.biomaterials.2012.05.015. View

14.

Meirow D, Raanani H, Shapira M, Brenghausen M, Derech Chaim S, Aviel-Ronen S . Transplantations of frozen-thawed ovarian tissue demonstrate high reproductive performance and the need to revise restrictive criteria. Fertil Steril. 2016; 106(2):467-74. DOI: 10.1016/j.fertnstert.2016.04.031. View

15.

Amiot C, Angelot-Delettre F, Zver T, Alvergnas-Vieille M, Saas P, Garnache-Ottou F . Minimal residual disease detection of leukemic cells in ovarian cortex by eight-color flow cytometry. Hum Reprod. 2013; 28(8):2157-67. DOI: 10.1093/humrep/det126. View

16.

Dolmans M, Luyckx V, Donnez J, Andersen C, Greve T . Risk of transferring malignant cells with transplanted frozen-thawed ovarian tissue. Fertil Steril. 2013; 99(6):1514-22. DOI: 10.1016/j.fertnstert.2013.03.027. View

17.

Fujita K, Ohta H, Tsujimura A, Takao T, Miyagawa Y, Takada S . Transplantation of spermatogonial stem cells isolated from leukemic mice restores fertility without inducing leukemia. J Clin Invest. 2005; 115(7):1855-61. PMC: 1150287. DOI: 10.1172/JCI24189. View

18.

Rosendahl M, Greve T, Andersen C . The safety of transplanting cryopreserved ovarian tissue in cancer patients: a review of the literature. J Assist Reprod Genet. 2012; 30(1):11-24. PMC: 3553351. DOI: 10.1007/s10815-012-9912-x. View

19.

Anderson R, Wallace W . Antimüllerian hormone, the assessment of the ovarian reserve, and the reproductive outcome of the young patient with cancer. Fertil Steril. 2013; 99(6):1469-75. DOI: 10.1016/j.fertnstert.2013.03.014. View

20.

Dolmans M, Michaux N, Camboni A, Martinez-Madrid B, Van Langendonckt A, Nottola S . Evaluation of Liberase, a purified enzyme blend, for the isolation of human primordial and primary ovarian follicles. Hum Reprod. 2005; 21(2):413-20. DOI: 10.1093/humrep/dei320. View